HEXO strengthens leadership team, appoints Donald Courtney as Chief Operating Officer
May 22 2019 - 6:30AM
HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NYSE-A: HEXO) is
further strengthening its leadership team by appointing Donald
Courtney as Chief Operating Officer.
“I am really pleased to welcome Donald to our leadership team,”
said HEXO Corp CEO and co-founder Sebastien St-Louis. “His
experience with innovative, technology-driven companies and his
in-depth knowledge of the cannabis industry are great assets to
HEXO as we work to create consistent cannabis experiences through a
full range of products developed in partnership with Fortune 500
companies. Donald is also a reputable leader and I look forward to
seeing him in action with the HEXO team.”
Donald Courtney boasts over 20 years of experience in senior
operations positions across several industries, including previous
experience in the cannabis industry. Donald has extensive
experience with several global food and beverage organizations
including Mars Inc, Pepsi Bottling Group and Vincor International
and experience in technology with Christie Digital and LG
Electronics. Most recently, Donald served as the Chief Operating
Officer for MedReleaf.
“I am thrilled to join such a people-centred organization. HEXO
Corp has clearly defined growth strategies and a bright future, and
I am grateful to be a part of this dynamic organization,” stated
Donald Courtney.
About HEXO Corp
HEXO Corp is an award-winning consumer packaged
goods cannabis company that creates and distributes prize-winning
products to serve the global cannabis market. Through its hub and
spoke business strategy, HEXO Corp is partnering with Fortune 500
companies, bringing its brand value, cannabinoid isolation
technology, licensed infrastructure and regulatory expertise to
established companies, leveraging their distribution networks and
capacity. As one of the largest licensed cannabis companies in
Canada, HEXO Corp operates with 1.8 million sq. ft of facilities in
Ontario and Quebec and has a foothold in Greece to establish a
Eurozone processing, production and distribution centre. The
Company serves the Canadian adult-use and medical markets. For more
information please visit hexocorp.com.
Forward-Looking Statements
This press release contains forward-looking
information and forward-looking statements within the meaning of
applicable securities laws (“forward-looking statements”).
Forward-looking statements are based on certain expectations and
assumptions and are subject to known and unknown risks and
uncertainties and other factors that could cause actual events,
results, performance and achievements to differ materially from
those anticipated in these forward-looking statements.
Forward-looking statements should not be read as guarantees of
future performance or results. A more complete discussion of the
risks and uncertainties facing the Company appears in the Company’s
Annual Information Form and other continuous disclosure filings,
which are available on SEDAR at www.sedar.com and EDGAR at
www.sec.gov. Readers are cautioned not to place undue reliance on
these forward-looking statements, which speak only as of the date
of this press release. The Company disclaims any intention or
obligation, except to the extent required by law, to update or
revise any forward-looking statements as a result of new
information or future events, or for any other reason.
Investor Relations:
Jennifer Smith1-866-438-8429invest@HEXO.comwww.hexocorp.com
Media Relations:
Caroline Milliard(819) 317-0526media@hexo.com
Director
Adam Miron819-639-5498
HEXO (NASDAQ:HEXO)
Historical Stock Chart
From Aug 2024 to Sep 2024
HEXO (NASDAQ:HEXO)
Historical Stock Chart
From Sep 2023 to Sep 2024